Owens & Minor

Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 20, 2024

Such elements include, but are not limited to, restructuring and acquisition charges, which could have a significant and unpredictable impact on our GAAP results.

Key Points: 
  • Such elements include, but are not limited to, restructuring and acquisition charges, which could have a significant and unpredictable impact on our GAAP results.
  • Owens & Minor executives will host a conference call for investors and analysts on Tuesday, February 20, 2024, at 8:30 a.m.
  • All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/.
  • Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call

Retrieved on: 
Thursday, February 8, 2024

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange.
  • The Company will host a conference call for investors and analysts at 8:30 a.m.
  • Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437.
  • All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/ .

HR Pharmaceuticals, Inc. receives exclusive commercialization rights to Poiesis Medical's Dual Balloon Catheter technology in North America

Retrieved on: 
Thursday, December 28, 2023

YORK, Pa., Dec. 28, 2023 /PRNewswire/ -- Today, HR Pharmaceuticals, Inc. (HRP) announced that they have entered into an Exclusive Commercial Agreement with Poiesis Medical LLC, under which HRP will license Poiesis's Dual Balloon Catheter (Duette™).

Key Points: 
  • YORK, Pa., Dec. 28, 2023 /PRNewswire/ -- Today, HR Pharmaceuticals, Inc. (HRP) announced that they have entered into an Exclusive Commercial Agreement with Poiesis Medical LLC, under which HRP will license Poiesis's Dual Balloon Catheter (Duette™).
  • Under the terms of the agreement, HRP will have exclusive commercialization rights in North America.
  • "The Dual Balloon Catheter has demonstrated significant benefits compared to traditional Foley catheters, leading to better patient outcomes.
  • HRP will begin processing North American orders for the Duette Dual Balloon Catheters starting January 2, 2024.

Owens & Minor Launches Life Takes Care™

Retrieved on: 
Thursday, December 7, 2023

Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care.
  • Life Takes Care was uncovered and developed using teammate perspectives as well as strategic insights from company leadership.
  • Life Takes Care was first unveiled on December 6, 2023 and will be celebrated throughout its inaugural year in 2024.
  • To learn more about Life Takes Care and Owens & Minor’s vital role in healthcare, visit www.owens-minor.com/about .

Owens & Minor Unveils Long-Term Strategy at Investor Day Today

Retrieved on: 
Wednesday, December 6, 2023

“We are excited to launch our long-term strategy focused on enhancing both the cash generation and profitability profiles of our businesses.

Key Points: 
  • “We are excited to launch our long-term strategy focused on enhancing both the cash generation and profitability profiles of our businesses.
  • We also simultaneously plan to improve the margin profile of our Products & Healthcare Services segment,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.
  • Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
  • Owens & Minor uses its web site, www.owens-minor.com , as a channel of distribution for material Company information, including news releases, investor presentations and financial information.

Owens & Minor Announces Upcoming Investor Day on December 6th

Retrieved on: 
Wednesday, November 29, 2023

Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it will host an Investor Day for investors and research analysts on Wednesday, December 6th at Convene in Boston, Massachusetts.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it will host an Investor Day for investors and research analysts on Wednesday, December 6th at Convene in Boston, Massachusetts.
  • The event will feature presentations from members of the senior executive leadership team, who will share the Company’s strategic vision, operating and growth strategy, and multi-year financial targets.
  • The event will begin at 8:30 a.m. Eastern Standard Time (EST) and is expected to conclude at 12:00 p.m. EST.
  • A replay of the webcast can be accessed following the presentation at the link provided above.

I2Pure Hires Healthcare Industry Leader as Chief Executive Officer

Retrieved on: 
Tuesday, November 7, 2023

Today, I2Pure announced the hiring of its new Chief Executive Officer, Jeffrey Jochims, effective November 1, 2023.

Key Points: 
  • Today, I2Pure announced the hiring of its new Chief Executive Officer, Jeffrey Jochims, effective November 1, 2023.
  • We’re elated to have someone of Jeff’s experience and capabilities join our company as Chief Executive Officer,” said Doug Spitz, I2Pure Founder.
  • We’re humbled and proud that I2Pure has been able to attract and retain an executive leader of Jeff’s caliber.
  • About I2Pure: I2Pure is a healthcare technology company dedicated to advancing the world of health and biosafety by preventing infections and disease through its patented, non-toxic molecular iodine platform.

Owens & Minor Reports Third Quarter 2023 Financial Results

Retrieved on: 
Friday, November 3, 2023

Such elements include, but are not limited to, restructuring and acquisition charges, which could have a significant and unpredictable impact on our GAAP results.

Key Points: 
  • Such elements include, but are not limited to, restructuring and acquisition charges, which could have a significant and unpredictable impact on our GAAP results.
  • Owens & Minor executives will host a conference call for investors and analysts at 8:00 a.m.
  • All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/ .
  • Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

United Medical Systems Appoints Seasoned Healthcare and Sales Executive Matthew Gattuso as President

Retrieved on: 
Monday, October 30, 2023

United Medical Systems Inc. (“UMS”), a national provider of premier transportable and in-house urology solutions to hospitals, surgery centers, and offices, today announced the appointment of Matthew Gattuso as President, effective November 1, 2023.

Key Points: 
  • United Medical Systems Inc. (“UMS”), a national provider of premier transportable and in-house urology solutions to hospitals, surgery centers, and offices, today announced the appointment of Matthew Gattuso as President, effective November 1, 2023.
  • Most recently, Mr. Gattuso served as Senior Vice President and Commercial Sales Leader at Owens & Minor, Inc., a Fortune 500 global healthcare solutions company.
  • Mr. Gattuso is a seasoned commercial business leader with three decades of experience in the healthcare and medical device industries.
  • During his tenure at Owens & Minor, he oversaw all aspects of the merged Owens & Minor and Halyard Medical Distribution, Enterprise, Products, and Services commercial selling organizations in the United States.

Owens & Minor Announces Third Quarter 2023 Earnings Release Date and Conference Call

Retrieved on: 
Tuesday, October 24, 2023

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange.
  • The Company will host a conference call for investors and analysts at 8:00 a.m.
  • Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437.
  • All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/ .